4.7 Article

Multiplex PCR and Emerging Technologies for the Detection of Respiratory Pathogens

Journal

CLINICAL INFECTIOUS DISEASES
Volume 52, Issue -, Pages S326-S330

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/cir047

Keywords

-

Funding

  1. Food and Drug Administration
  2. Infectious Diseases Society of America
  3. AstraZeneca Pharmaceuticals
  4. Bio Merieux, Inc.
  5. Cepheid
  6. Gilead Sciences
  7. Intelligent MDX, Inc.
  8. Inverness Medical Innovations
  9. Roche Molecular Systems
  10. Qiagen
  11. Roche Molecular

Ask authors/readers for more resources

Molecular methods are becoming more widely used for the detection of respiratory pathogens, in part because of their superior sensitivity, relatively rapid turnaround time, and ability to identify pathogens that are slow growing or difficult to culture. The recent novel H1N1 influenza A pandemic served to underscore how quickly new molecular tests can become available for clinical use. Over the years PCR has been the dominant amplification method. Recently, modifications of this technology have emerged, some of which allow for the rapid detection of multiple pathogens in a single test. This review will focus on emerging multiplex molecular technologies and their clinical utility for the detection of respiratory pathogens.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available